221 related articles for article (PubMed ID: 26162101)
1. Criterion Validation Testing of Clinical Metrology Instruments for Measuring Degenerative Joint Disease Associated Mobility Impairment in Cats.
Gruen ME; Griffith EH; Thomson AE; Simpson W; Lascelles BD
PLoS One; 2015; 10(7):e0131839. PubMed ID: 26162101
[TBL] [Abstract][Full Text] [Related]
2. Detection of clinically relevant pain relief in cats with degenerative joint disease associated pain.
Gruen ME; Griffith E; Thomson A; Simpson W; Lascelles BD
J Vet Intern Med; 2014; 28(2):346-50. PubMed ID: 24512390
[TBL] [Abstract][Full Text] [Related]
3. Feline musculoskeletal pain index: responsiveness and testing of criterion validity.
Benito J; Hansen B; Depuy V; Davidson GS; Thomson A; Simpson W; Roe S; Hardie E; Lascelles BD
J Vet Intern Med; 2013; 27(3):474-82. PubMed ID: 23551140
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of client-specific outcome measures and activity monitoring to measure pain relief in cats with osteoarthritis.
Lascelles BD; Hansen BD; Roe S; DePuy V; Thomson A; Pierce CC; Smith ES; Rowinski E
J Vet Intern Med; 2007; 21(3):410-6. PubMed ID: 17552444
[TBL] [Abstract][Full Text] [Related]
5. A Feline-Specific Anti-Nerve Growth Factor Antibody Improves Mobility in Cats with Degenerative Joint Disease-Associated Pain: A Pilot Proof of Concept Study.
Gruen ME; Thomson AE; Griffith EH; Paradise H; Gearing DP; Lascelles BD
J Vet Intern Med; 2016 Jul; 30(4):1138-48. PubMed ID: 27334504
[TBL] [Abstract][Full Text] [Related]
6. Reliability and discriminatory testing of a client-based metrology instrument, feline musculoskeletal pain index (FMPI) for the evaluation of degenerative joint disease-associated pain in cats.
Benito J; Depuy V; Hardie E; Zamprogno H; Thomson A; Simpson W; Roe S; Hansen B; Lascelles BD
Vet J; 2013 Jun; 196(3):368-73. PubMed ID: 23369382
[TBL] [Abstract][Full Text] [Related]
7. Comparison of meloxicam and a glucosamine-chondroitin supplement in management of feline osteoarthritis. A double-blind randomised, placebo-controlled, prospective trial.
Sul RM; Chase D; Parkin T; Bennett D
Vet Comp Orthop Traumatol; 2014; 27(1):20-6. PubMed ID: 24146058
[TBL] [Abstract][Full Text] [Related]
8. Caregiver placebo effect in analgesic clinical trials for cats with naturally occurring degenerative joint disease-associated pain.
Gruen ME; Dorman DC; Lascelles BDX
Vet Rec; 2017 May; 180(19):473. PubMed ID: 28270539
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a nutritional supplement for the alleviation of pain associated with feline degenerative joint disease: a prospective, randomized, stratified, double-blind, placebo-controlled clinical trial.
Cunningham R; Gruen ME; Thomson A; Lascelles BDX
J Feline Med Surg; 2022 Oct; 24(10):962-974. PubMed ID: 34719996
[TBL] [Abstract][Full Text] [Related]
10. Analgesic efficacy of an oral transmucosal spray formulation of meloxicam alone or in combination with tramadol in cats with naturally occurring osteoarthritis.
Monteiro BP; Klinck MP; Moreau M; Guillot M; Steagall PV; Edge DK; Pelletier JP; Martel-Pelletier J; Gauvin D; Del Castillo JR; Troncy E
Vet Anaesth Analg; 2016 Nov; 43(6):643-651. PubMed ID: 26913836
[TBL] [Abstract][Full Text] [Related]
11. Refinement of the Feline Musculoskeletal Pain Index (FMPI) and development of the short-form FMPI.
Enomoto M; Lascelles BDX; Robertson JB; Gruen ME
J Feline Med Surg; 2022 Feb; 24(2):142-151. PubMed ID: 34002643
[TBL] [Abstract][Full Text] [Related]
12. Frunevetmab, a felinized anti-nerve growth factor monoclonal antibody, for the treatment of pain from osteoarthritis in cats.
Gruen ME; Myers JAE; Tena JS; Becskei C; Cleaver DM; Lascelles BDX
J Vet Intern Med; 2021 Nov; 35(6):2752-2762. PubMed ID: 34724255
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of meloxicam for the treatment of obstructive feline idiopathic cystitis.
Dorsch R; Zellner F; Schulz B; Sauter-Louis C; Hartmann K
J Feline Med Surg; 2016 Nov; 18(11):925-933. PubMed ID: 26672127
[TBL] [Abstract][Full Text] [Related]
14. Retrospective case-control study of the effects of long-term dosing with meloxicam on renal function in aged cats with degenerative joint disease.
Gowan RA; Lingard AE; Johnston L; Stansen W; Brown SA; Malik R
J Feline Med Surg; 2011 Oct; 13(10):752-61. PubMed ID: 21906984
[TBL] [Abstract][Full Text] [Related]
15. Robenacoxib versus meloxicam for the control of peri-operative pain and inflammation associated with orthopaedic surgery in cats: a randomised clinical trial.
Speranza C; Schmid V; Giraudel JM; Seewald W; King JN
BMC Vet Res; 2015 Mar; 11():79. PubMed ID: 25880535
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of meloxicam versus ketoprofen in cats suffering from painful acute locomotor disorders.
Morton CM; Grant D; Johnston L; Letellier IM; Narbe R
J Feline Med Surg; 2011 Apr; 13(4):237-43. PubMed ID: 21354843
[TBL] [Abstract][Full Text] [Related]
17. Characterization of osteoarthritis in cats and meloxicam efficacy using objective chronic pain evaluation tools.
Guillot M; Moreau M; Heit M; Martel-Pelletier J; Pelletier JP; Troncy E
Vet J; 2013 Jun; 196(3):360-7. PubMed ID: 23416029
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the effects of gabapentin on activity levels and owner-perceived mobility impairment and quality of life in osteoarthritic geriatric cats.
Guedes AGP; Meadows JM; Pypendop BH; Johnson EG; Zaffarano B
J Am Vet Med Assoc; 2018 Sep; 253(5):579-585. PubMed ID: 30110208
[TBL] [Abstract][Full Text] [Related]
19. Multicenter randomized prospective clinical evaluation of meloxicam administered via transmucosal oral spray in client-owned dogs.
Cozzi EM; Spensley MS
J Vet Pharmacol Ther; 2013 Dec; 36(6):609-16. PubMed ID: 23550740
[TBL] [Abstract][Full Text] [Related]
20. Owner evaluation of quality of life and mobility in osteoarthritic cats treated with amantadine or placebo.
Shipley H; Flynn K; Tucker L; Wendt-Hornickle E; Baldo C; Almeida D; Allweiler S; Guedes A
J Feline Med Surg; 2021 Jun; 23(6):568-574. PubMed ID: 33112193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
